Nvest Financial LLC bought a new position in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 15,536 shares of the company's stock, valued at approximately $571,000.
Several other hedge funds have also recently modified their holdings of AHR. Wolff Wiese Magana LLC purchased a new position in shares of American Healthcare REIT in the first quarter worth $25,000. Spirit of America Management Corp NY purchased a new position in shares of American Healthcare REIT in the first quarter worth $30,000. Physician Wealth Advisors Inc. purchased a new position in shares of American Healthcare REIT in the second quarter worth $34,000. Avalon Trust Co purchased a new position in shares of American Healthcare REIT in the first quarter worth $36,000. Finally, Continuum Advisory LLC purchased a new position in shares of American Healthcare REIT in the first quarter worth $37,000. Hedge funds and other institutional investors own 16.68% of the company's stock.
American Healthcare REIT Price Performance
American Healthcare REIT stock opened at $42.73 on Thursday. The company has a market cap of $7.20 billion, a price-to-earnings ratio of -194.24, a PEG ratio of 2.13 and a beta of 0.98. The firm's fifty day moving average is $41.81 and its 200 day moving average is $36.92. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.41. American Healthcare REIT, Inc. has a 52-week low of $24.21 and a 52-week high of $43.52.
American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The company had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. During the same quarter in the prior year, the firm earned $0.33 earnings per share. American Healthcare REIT's revenue was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Sell-side analysts forecast that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.
American Healthcare REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.25 per share. The ex-dividend date is Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.3%. American Healthcare REIT's payout ratio is -454.55%.
Insiders Place Their Bets
In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the business's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the transaction, the executive vice president owned 59,100 shares in the company, valued at $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.92% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several research firms have recently commented on AHR. Scotiabank reissued an "outperform" rating on shares of American Healthcare REIT in a report on Thursday, August 28th. KeyCorp boosted their target price on shares of American Healthcare REIT from $40.00 to $43.00 and gave the stock an "overweight" rating in a report on Tuesday. Morgan Stanley reissued an "overweight" rating on shares of American Healthcare REIT in a report on Wednesday, September 3rd. Royal Bank Of Canada upped their price target on shares of American Healthcare REIT from $39.00 to $45.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Finally, Robert W. Baird assumed coverage on shares of American Healthcare REIT in a research note on Friday, July 18th. They set an "outperform" rating and a $41.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, American Healthcare REIT currently has a consensus rating of "Buy" and a consensus price target of $44.44.
View Our Latest Stock Analysis on American Healthcare REIT
About American Healthcare REIT
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.